PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--ForteBio, a division of Pall Life Sciences and a leading supplier of instrumentation for accelerated drug discovery and development, today announced the launch ...
The Octet HTX instrument monitors up to 96 biosensors simultaneously, enabling label-free detection for protein quantitation and kinetic characterization at unmatched speed. The system's ability to ...
Innovative label-free technologies such as biolayer interferometry (BLI) and advances in biosensor technology over the past several years have been addressing the growing demand and requirements for ...
Antibodies are frequently produced from a cell line that has been screened to ensure the protein is expressed with the desired post-translational modifications, target specificity and affinity, and at ...
Label-free technologies provide critical information for the drug discovery process—from the screening of specific drug target binding interactions, to measuring the affinity of that binding. When ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results